Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Figure 1 Elevated flap endonuclease-1 expression in pancreatic cancer correlates with poor prognosis.
A: Analysis of flap endonuclease-1 (FEN1) mRNA expression in pancreatic cancer (PC) tissues derived from The Cancer Genome Atlas and Genotype-Tissue Expression databases; B: Box plots depicting FEN1 expression across six independent PC microarray datasets; C: Correlation analysis between FEN1 expression levels and overall survival and disease-free survival in PC patients, based on Gene Expression Profiling Interactive Analysis database; D: Western blot analysis of FEN1 protein expression in human pancreatic cell line cells and five PC cell lines; E: Comparative analysis of FEN1 protein expression in eight paired PC tissues and adjacent non-tumor tissues; F: Analysis of FEN1 expression patterns across PC cell lines from the Cancer Cell Line Encyclopedia database. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Xia Y, Guo N, Zhu CL, Gao JY, Da MX. Flap endonuclease-1 promotes pancreatic cancer progression via AKT/mTOR signaling pathway. World J Gastrointest Oncol 2025; 17(7): 104402
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/104402.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.104402